European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment
Allergy2016Vol. 72(3), pp. 462–472
Citations Over TimeTop 10% of 2016 papers
Moisés A. Calderón, Carmen Vidal, Pablo Rodríguez del Río, J. Just, Oliver Pfaar, A. I. Tabar, Inmaculada Sánchez‐Machín, Petra Bubel, J. Borja, Peter Eberle, Rainer Reiber, Michel Bouvier, A. Lepelliez, L. Klimek, Pascal Demoly, on behalf of the EASSI Doctors' Group
Abstract
AIT for respiratory allergy is safe, with a low number of SRs observed in real-life clinical practice. A personalized analysis of risk factors could be used to minimize SRs.
Related Papers
- → A knowledge based approach for automated signal generation in pharmacovigilance(2004)15 cited
- → Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance(2005)45 cited
- → Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database(2011)13 cited
- → Exploitation de la distance sémantique pour la création de groupements de termes en pharmacovigilance(2011)2 cited
- → Coding in Pharmacovigilance Using MedDRA: A Review(2022)